BreastCancerProteomes / Git / [fce109] /clinical_data_breast

Datasets:

ClarissaAdler/

BreastCancerProteomes

Downloads: 1

[fce109]: / clinical_data_breast_cancer.csv

History

Download this file

#	Complete TCGA ID	Gender	Age at Initial Pathologic Diagnosis	ER Status	PR Status	HER2 Final Status	Tumor	Tumor--T1 Coded	Node	Node-Coded	Metastasis	Metastasis-Coded	AJCC Stage	Converted Stage	Survival Data Form	Vital Status	Days to Date of Last Contact	Days to date of Death	OS event	OS Time	PAM50 mRNA	SigClust Unsupervised mRNA	SigClust Intrinsic mRNA	miRNA Clusters	methylation Clusters	RPPA Clusters	CN Clusters	Integrated Clusters (with PAM50)	Integrated Clusters (no exp)	Integrated Clusters (unsup exp)
1	TCGA-A2-A0T2	FEMALE	66	Negative	Negative	Negative	T3	T_Other	N3	Positive	M1	Positive	Stage IV	No_Conversion	followup	DECEASED	240	240	1	240	Basal-like	0	-13	3	5	Basal	3	2	2	2
2	TCGA-A2-A0CM	FEMALE	40	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	DECEASED	754	754	1	754	Basal-like	-12	-13	4	4	Basal	4	2	1	1
3	TCGA-BH-A18V	FEMALE	48	Negative	Negative	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	No_Conversion	enrollment	DECEASED	1555	1555	1	1555	Basal-like	-12	-13	5	5	Basal	1	2	2	2
4	TCGA-BH-A18Q	FEMALE	56	Negative	Negative	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	No_Conversion	enrollment	DECEASED	1692	1692	1	1692	Basal-like	-12	-13	5	5	Basal	1	2	2	2
5	TCGA-BH-A0E0	FEMALE	38	Negative	Negative	Negative	T3	T_Other	N3	Positive	M0	Negative	Stage IIIC	No_Conversion	followup	LIVING	133	NA	0	133	Basal-like	0	-13	5	5	Basal	1	2	2	2
6	TCGA-A7-A0CE	FEMALE	57	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	309	NA	0	309	Basal-like	0	-13	5	5	Basal	1	2	2	2
7	TCGA-D8-A142	FEMALE	74	Negative	Negative	Negative	T3	T_Other	N0	Negative	M0	Negative	Stage IIB	Stage IIB	followup	LIVING	425	NA	0	425	Basal-like	0	-13	3	5	X	1	2	2	2
8	TCGA-A2-A0D0	FEMALE	60	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	643	NA	0	643	Basal-like	-12	-13	5	5	Basal	1	2	2	2
9	TCGA-AO-A0J6	FEMALE	61	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	775	NA	0	775	Basal-like	-12	-13	2	5	Basal	1	2	2	2
10	TCGA-A2-A0YM	FEMALE	67	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	964	NA	0	964	Basal-like	-12	-13	5	5	Basal	3	2	2	2
11	TCGA-A2-A0D2	FEMALE	45	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIB	Stage IIA	followup	LIVING	1027	NA	0	1027	Basal-like	-12	-13	4	5	Basal	3	2	2	2
12	TCGA-A2-A0SX	FEMALE	48	Negative	Negative	Negative	T1	T1	N0	Negative	M0	Negative	Stage IA	Stage I	followup	LIVING	1288	NA	0	1288	Basal-like	-12	-13	4	5	Basal	1	2	2	2
13	TCGA-AO-A0JL	FEMALE	59	Negative	Negative	Negative	T2	T_Other	N2	Positive	M0	Negative	Stage IIIA	No_Conversion	followup	LIVING	1319	NA	0	1319	Basal-like	0	-13	5	5	Basal	3	2	2	2
14	TCGA-AO-A12F	FEMALE	36	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	1471	NA	0	1471	Basal-like	0	-13	5	5	Basal	1	2	2	2
15	TCGA-AN-A0AL	FEMALE	41	Negative	Negative	Negative	T4	T_Other	N0	Negative	M0	Negative	Stage IIIB	No_Conversion	enrollment	LIVING	197	NA	0	197	Basal-like	0	-13	3	5	Basal	1	2	2	2
16	TCGA-AN-A0FL	FEMALE	62	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	No_Conversion	enrollment	LIVING	230	NA	0	230	Basal-like	0	-13	5	5	Basal	1	2	2	2
17	TCGA-AR-A0U4	FEMALE	54	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage II	No_Conversion	enrollment	LIVING	1627	NA	0	1627	Basal-like	-12	-13	5	5	ReacII	1	2	2	2
18	TCGA-AR-A1AQ	FEMALE	49	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage II	Stage IIA	enrollment	LIVING	1309	NA	0	1309	Basal-like	-12	-13	3	5	Basal	1	2	2	2
19	TCGA-BH-A0AV	FEMALE	52	Negative	Negative	Negative	T1	T1	N0	Negative	M0	Negative	Stage I	Stage I	enrollment	LIVING	1180	NA	0	1180	Basal-like	0	-13	4	5	ReacII	1	2	2	2
20	TCGA-C8-A12V	FEMALE	55	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	enrollment	LIVING	0	NA	0	0	Basal-like	-12	-13	3	5	Basal	1	2	2	2
21	TCGA-C8-A131	FEMALE	82	Negative	Negative	Negative	T2	T_Other	N2	Positive	M0	Negative	Stage III	Stage IIIA	enrollment	LIVING	0	NA	0	0	Basal-like	0	-13	5	1	ReacII	1	2	2	2
22	TCGA-C8-A134	FEMALE	52	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	No_Conversion	enrollment	LIVING	0	NA	0	0	Basal-like	-12	-13	6	4	Basal	1	2	2	2
23	TCGA-E2-A150	FEMALE	48	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	enrollment	LIVING	591	NA	0	591	Basal-like	-12	-13	3	5	X	1	2	2	2
24	TCGA-E2-A158	FEMALE	43	Negative	Negative	Negative	T1	T1	N1	Positive	M0	Negative	Stage IIA	Stage IIA	enrollment	LIVING	450	NA	0	450	Basal-like	0	-13	5	5	Basal	1	2	2	2
25	TCGA-E2-A159	FEMALE	50	Negative	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	enrollment	LIVING	515	NA	0	515	Basal-like	-10	-13	3	5	Basal	1	2	2	2
26	TCGA-BH-A18R	FEMALE	50	Indeterminate	Negative	Positive	T2	T_Other	N1	Positive	M0	Negative	Stage IB	No_Conversion	enrollment	DECEASED	1099	1141	1	1141	HER2-enriched	0	-2	4	4	Her2	3	1	1	1
27	TCGA-A2-A0T1	FEMALE	55	Negative	Negative	Positive	T3	T_Other	N3	Positive	M0	Negative	Stage IIIC	No_Conversion	followup	LIVING	520	NA	0	520	HER2-enriched	-5	-11	4	5	Her2	4	1	1	1
28	TCGA-BH-A0EE	FEMALE	68	Negative	Negative	Positive	T3	T_Other	N0	Negative	M0	Negative	Stage IIB	Stage IIB	followup	LIVING	943	NA	0	943	HER2-enriched	-9	-11	7	1	Basal	5	1	2	3
29	TCGA-A2-A0D1	FEMALE	76	Negative	Negative	Positive	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	1051	NA	0	1051	HER2-enriched	-6	-2	1	3	Basal	1	1	2	2
30	TCGA-AO-A12D	FEMALE	43	Negative	Negative	Positive	T1	T1	N1	Positive	M0	Negative	Stage IIA	No_Conversion	followup	LIVING	1948	NA	0	1948	HER2-enriched	-10	-11	3	5	Her2	3	1	2	2
31	TCGA-AO-A0JE	FEMALE	53	Negative	Negative	Positive	T2	T_Other	N2	Positive	M0	Negative	Stage IIIA	No_Conversion	followup	LIVING	1965	NA	0	1965	HER2-enriched	-5	-11	4	4	Her2	5	1	1	1
32	TCGA-A2-A0EQ	FEMALE	64	Negative	Negative	Positive	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	2426	NA	0	2426	HER2-enriched	-5	-2	5	4	Basal	4	4	1	1
33	TCGA-A8-A076	FEMALE	66	Positive	Positive	Positive	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	enrollment	LIVING	1641	NA	0	1641	HER2-enriched	-5	-2	4	3	Her2	4	1	1	1
34	TCGA-A8-A09G	FEMALE	79	Positive	Negative	Positive	T3	T_Other	N3	Positive	M0	Negative	Stage IIIC	Stage IIIC	enrollment	LIVING	0	NA	0	0	HER2-enriched	-5	-11	3	1	Her2	2	1	3	2
35	TCGA-AR-A0TX	FEMALE	64	Positive	Positive	Positive	T1	T1	N1	Positive	M0	Negative	Stage II	No_Conversion	enrollment	LIVING	15	NA	0	15	HER2-enriched	-5	-11	1	1	ReacII	1	1	2	2
36	TCGA-C8-A12L	FEMALE	67	Negative	Negative	Positive	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	enrollment	LIVING	0	NA	0	0	HER2-enriched	-9	-11	4	4	Her2	1	1	1	1
37	TCGA-C8-A12P	FEMALE	55	Negative	Negative	Positive	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	No_Conversion	enrollment	LIVING	0	NA	0	0	HER2-enriched	-10	-11	4	1	Her2	3	1	1	1
38	TCGA-C8-A12Q	FEMALE	78	Negative	Negative	Positive	T1	T1	N2	Positive	M0	Negative	Stage IIIA	No_Conversion	enrollment	LIVING	0	NA	0	0	HER2-enriched	-5	-11	4	2	Her2	5	1	1	1
39	TCGA-C8-A12T	FEMALE	43	Positive	Positive	Positive	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	enrollment	LIVING	0	NA	0	0	HER2-enriched	-1	-2	4	4	ReacII	4	1	1	1
40	TCGA-C8-A12Z	FEMALE	45	Negative	Negative	Positive	T2	T_Other	N1	Positive	M0	Negative	Stage II	Stage IIB	enrollment	LIVING	0	NA	0	0	HER2-enriched	-5	-11	4	4	Her2	2	1	1	1
41	TCGA-C8-A130	FEMALE	52	Positive	Positive	Equivocal	T3	T_Other	N2	Positive	M0	Negative	Stage IIIA	Stage IIIA	enrollment	LIVING	0	NA	0	0	HER2-enriched	0	-2	4	2	Her2	1	1	1	1
42	TCGA-C8-A135	FEMALE	64	Negative	Negative	Positive	T2	T_Other	N1	Positive	M0	Negative	Stage II	Stage IIB	enrollment	LIVING	0	NA	0	0	HER2-enriched	-5	-11	7	1	Her2	1	1	2	2
43	TCGA-C8-A138	FEMALE	54	Positive	Negative	Positive	T2	T_Other	N2	Positive	M0	Negative	Stage III	Stage IIIA	enrollment	LIVING	7	NA	0	7	HER2-enriched	-5	-2	1	2	Basal	2	1	3	2
44	TCGA-AR-A0TR	FEMALE	68	Positive	Positive	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage II	No_Conversion	enrollment	DECEASED	21	160	1	160	Luminal A	-3	-12	7	2	LumA/B	1	3	3	3
45	TCGA-BH-A18N	FEMALE	88	Positive	Positive	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage IIA	No_Conversion	enrollment	DECEASED	1148	1148	1	1148	Luminal A	-3	-12	6	2	LumA	3	3	3	3
46	TCGA-BH-A0HK	FEMALE	81	Positive	Negative	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	No_Conversion	followup	LIVING	178	NA	0	178	Luminal A	0	0	7	3	LumA/B	2	3	3	3
47	TCGA-A7-A0CD	FEMALE	66	Positive	Positive	Negative	T1	T1	N0	Negative	M0	Negative	Stage IA	Stage I	followup	LIVING	372	NA	0	372	Luminal A	-3	-10	2	3	LumA	3	3	4	3
48	TCGA-BH-A0HP	FEMALE	65	Positive	Negative	Negative	T3	T_Other	N2	Positive	M0	Negative	Stage IIIA	No_Conversion	followup	LIVING	414	NA	0	414	Luminal A	-7	-5	6	1	ReacI	2	3	3	4
49	TCGA-A2-A0YI	FEMALE	62	Positive	Positive	Negative	T1	T1	N0	Negative	M0	Negative	Stage IA	Stage I	followup	LIVING	441	NA	0	441	Luminal A	-4	-12	4	1	ReacI	3	3	1	4
50	TCGA-A2-A0YL	FEMALE	48	Positive	Positive	Negative	T3	T_Other	N2	Positive	M0	Negative	Stage IIIA	No_Conversion	followup	LIVING	445	NA	0	445	Luminal A	-7	-5	6	1	ReacI	2	3	3	4
51	TCGA-A2-A0YF	FEMALE	67	Positive	Negative	Negative	T1	T1	N0	Negative	M0	Negative	Stage IA	Stage I	followup	LIVING	469	NA	0	469	Luminal A	-3	-12	1	2	ReacII	2	3	3	3
52	TCGA-BH-A0E1	FEMALE	52	Positive	Positive	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	No_Conversion	followup	LIVING	477	NA	0	477	Luminal A	-3	-12	6	2	ReacII	2	3	3	3
53	TCGA-A2-A0T6	FEMALE	50	Positive	Positive	Negative	T3	T_Other	N0	Negative	M0	Negative	Stage IIB	Stage IIB	followup	LIVING	575	NA	0	575	Luminal A	-7	-5	2	4	ReacI	2	3	1	4
54	TCGA-A2-A0T7	FEMALE	51	Positive	Positive	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	631	NA	0	631	Luminal A	0	-3	4	1	ReacI	2	3	3	4
55	TCGA-A2-A0YD	FEMALE	63	Positive	Positive	Negative	T3	T_Other	N0	Negative	M0	Negative	Stage IIB	Stage IIB	followup	LIVING	769	NA	0	769	Luminal A	-7	-5	4	1	LumA	2	3	3	3
56	TCGA-A2-A0EV	FEMALE	80	Positive	Positive	Negative	T1	T1	N0	Negative	M0	Negative	Stage IA	Stage I	followup	LIVING	968	NA	0	968	Luminal A	-4	0	4	2	ReacI	3	3	3	4
57	TCGA-A2-A0YC	FEMALE	59	Positive	Positive	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	No_Conversion	followup	LIVING	989	NA	0	989	Luminal A	-3	-12	4	4	ReacII	2	3	1	3
58	TCGA-AO-A0J9	FEMALE	61	Positive	Positive	Negative	T2	T_Other	N3	Positive	M0	Negative	Stage IIIC	No_Conversion	followup	LIVING	1255	NA	0	1255	Luminal A	-3	-2	2	4	ReacI	2	3	1	4
59	TCGA-BH-A0BV	FEMALE	78	Positive	Positive	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	No_Conversion	followup	LIVING	1519	NA	0	1519	Luminal A	-4	0	7	4	LumA/B	5	3	1	3
60	TCGA-AO-A12E	FEMALE	51	Positive	Positive	Negative	T3	T_Other	N0	Negative	M0	Negative	Stage IIB	Stage IIB	followup	LIVING	1742	NA	0	1742	Luminal A	-7	-5	1	3	LumA/B	3	3	4	3
61	TCGA-AO-A126	FEMALE	39	Positive	Positive	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	2850	NA	0	2850	Luminal A	-3	0	6	4	Her2	5	3	1	3
62	TCGA-A2-A0EX	FEMALE	46	Positive	Positive	Negative	T3	T_Other	N0	Negative	M0	Negative	Stage IIB	Stage IIB	enrollment	LIVING	549	NA	0	549	Luminal A	-7	-5	4	4	ReacI	4	3	1	4
63	TCGA-AO-A0JJ	FEMALE	54	Positive	Positive	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	No_Conversion	enrollment	LIVING	1512	NA	0	1512	Luminal A	-7	-5	7	1	LumA/B	2	3	3	4
64	TCGA-A8-A08Z	FEMALE	76	Positive	Positive	Negative	T4	T_Other	N3	Positive	M0	Negative	Stage IIIB	Stage IIIC	enrollment	LIVING	1217	NA	0	1217	Luminal A	-3	-5	4	2	LumA	2	3	3	3
65	TCGA-AN-A04A	FEMALE	36	Positive	Positive	Negative	T2	T_Other	N2	Positive	M0	Negative	Stage IIIA	No_Conversion	enrollment	LIVING	89	NA	0	89	Luminal A	-3	-5	4	2	LumA/B	5	3	3	3
66	TCGA-AR-A1AP	FEMALE	80	Positive	Positive	Negative	T1	T1	N0	Negative	M0	Negative	Stage I	Stage I	enrollment	LIVING	1215	NA	0	1215	Luminal A	0	0	4	4	LumA/B	2	3	1	3
67	TCGA-AR-A1AS	FEMALE	54	Positive	Positive	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage II	Stage IIB	enrollment	LIVING	1242	NA	0	1242	Luminal A	-3	-7	4	2	LumA	3	3	3	3
68	TCGA-AR-A1AW	FEMALE	65	Positive	Positive	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage II	Stage IIA	enrollment	LIVING	1072	NA	0	1072	Luminal A	-3	-12	3	1	ReacII	3	3	2	2
69	TCGA-BH-A0C1	FEMALE	61	Positive	Positive	Negative	T3	T_Other	N2	Positive	M0	Negative	Stage IIIA	Stage IIIA	enrollment	LIVING	1338	NA	0	1338	Luminal A	-1	-1	5	4	ReacII	2	3	1	3
70	TCGA-BH-A0DG	FEMALE	30	Positive	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	enrollment	LIVING	713	NA	0	713	Luminal A	-4	-4	4	1	ReacI	3	3	1	4
71	TCGA-BH-A0E9	FEMALE	53	Positive	Positive	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	Stage IIB	enrollment	LIVING	1405	NA	0	1405	Luminal A	-7	-5	6	1	ReacI	3	3	3	4
72	TCGA-E2-A154	FEMALE	68	Positive	Positive	Negative	T1	T1	N0	Negative	M0	Negative	Stage I	Stage I	enrollment	LIVING	325	NA	0	325	Luminal A	-3	-12	6	4	LumA	2	3	3	3
73	TCGA-AO-A03O	FEMALE	69	Positive	Positive	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	DECEASED	993	2483	1	2483	Luminal B	-5	-2	1	4	LumA/B	3	4	1	1
74	TCGA-A2-A0SW	FEMALE	82	Positive	Negative	Negative	T2	T_Other	N2	Positive	M1	Positive	Stage IV	No_Conversion	followup	DECEASED	1364	1364	1	1364	Luminal B	-5	-2	3	4	Basal	4	4	1	1
75	TCGA-BH-A18U	FEMALE	72	Positive	Positive	Positive	T2	T_Other	N2	Positive	M0	Negative	Stage IIIA	Stage IIIA	enrollment	DECEASED	1317	1563	1	1563	Luminal B	-5	-2	5	3	ReacI	3	4	4	5
76	TCGA-AR-A0TY	FEMALE	54	Positive	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage II	No_Conversion	enrollment	DECEASED	544	1699	1	1699	Luminal B	-5	-2	4	4	LumA/B	1	4	1	1
77	TCGA-D8-A13Y	FEMALE	52	Positive	Positive	Negative	T1	T1	N0	Negative	M0	Negative	Stage IA	No_Conversion	followup	LIVING	362	NA	0	362	Luminal B	-6	-2	1	2	Basal	5	4	3	2
78	TCGA-A7-A13F	FEMALE	44	Positive	Positive	Negative	T3	T_Other	N1	Positive	M0	Negative	Stage IIIA	No_Conversion	followup	LIVING	387	NA	0	387	Luminal B	-3	0	4	4	LumA/B	3	4	1	3
79	TCGA-A7-A0CJ	FEMALE	57	Positive	Positive	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	409	NA	0	409	Luminal B	-3	-6	2	3	LumA/B	1	4	4	3
80	TCGA-A2-A0T3	FEMALE	37	Positive	Positive	Negative	T1	T1	N1	Positive	M0	Negative	Stage IA	Stage IIA	followup	LIVING	569	NA	0	569	Luminal B	-3	0	7	3	ReacII	3	4	4	5
81	TCGA-A2-A0YG	FEMALE	63	Positive	Positive	Positive	T2	T_Other	N3	Positive	M0	Negative	Stage IIIC	No_Conversion	followup	LIVING	665	NA	0	665	Luminal B	-5	-2	4	4	Her2	5	4	1	1
82	TCGA-A2-A0EY	FEMALE	62	Positive	Negative	Positive	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	No_Conversion	followup	LIVING	735	NA	0	735	Luminal B	-5	-2	1	4	Her2	3	4	1	1
83	TCGA-E2-A10A	FEMALE	41	Positive	Positive	Negative	T3	T_Other	N0	Negative	M0	Negative	Stage IIB	Stage IIB	followup	LIVING	1229	NA	0	1229	Luminal B	-3	0	1	2	LumA/B	2	4	3	3
84	TCGA-BH-A0C0	FEMALE	62	Positive	Positive	Positive	T1	T1	N1	Positive	M0	Negative	Stage IIA	No_Conversion	followup	LIVING	1270	NA	0	1270	Luminal B	-5	-2	4	4	Basal	3	4	1	1
85	TCGA-AO-A0JC	FEMALE	64	Positive	Positive	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	1547	NA	0	1547	Luminal B	-5	-2	2	5	LumA	1	2	2	2
86	TCGA-AO-A0JM	FEMALE	40	Positive	Positive	Positive	T2	T_Other	N1	Positive	M0	Negative	Stage IIB	No_Conversion	followup	LIVING	1826	NA	0	1826	Luminal B	-5	-2	5	3	ReacII	3	4	4	5
87	TCGA-AO-A12B	FEMALE	63	Positive	Positive	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	followup	LIVING	2359	NA	0	2359	Luminal B	-3	-12	3	2	LumA/B	3	4	3	3
88	TCGA-A8-A06N	FEMALE	66	Positive	Negative	Negative	T4	T_Other	N0	Negative	M0	Negative	Stage IIIB	Stage IIIB	enrollment	LIVING	0	NA	0	0	Luminal B	-3	-10	2	4	LumA/B	3	4	1	3
89	TCGA-A8-A06Z	FEMALE	84	Positive	Positive	Negative	T3	T_Other	N0	Negative	M0	Negative	Stage IIB	Stage IIB	enrollment	LIVING	31	NA	0	31	Luminal B	-3	-10	1	5	Her2	5	4	1	3
90	TCGA-A8-A079	FEMALE	69	Positive	Positive	Negative	T4	T_Other	N3	Positive	M0	Negative	Stage IIIB	Stage IIIC	enrollment	LIVING	274	NA	0	274	Luminal B	-3	-6	5	3	LumA/B	5	4	4	3
91	TCGA-A8-A08G	FEMALE	41	Positive	Positive	Positive	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	enrollment	LIVING	606	NA	0	606	Luminal B	-3	-10	4	2	LumA/B	3	4	3	3
92	TCGA-A8-A09I	FEMALE	84	Positive	Positive	Positive	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	Stage IIA	enrollment	LIVING	1006	NA	0	1006	Luminal B	-5	-2	4	3	Her2	5	4	1	1
93	TCGA-AN-A0AJ	FEMALE	79	Positive	Positive	Positive	T3	T_Other	N0	Negative	M0	Negative	Stage IIB	No_Conversion	enrollment	LIVING	243	NA	0	243	Luminal B	-5	-2	4	3	LumA	5	4	1	1
94	TCGA-AN-A0AM	FEMALE	56	Positive	Negative	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage IIA	No_Conversion	enrollment	LIVING	5	NA	0	5	Luminal B	-5	-2	4	4	LumA/B	3	4	1	1
95	TCGA-AN-A0AS	FEMALE	70	Positive	Negative	Negative	T2	T_Other	N2	Positive	M0	Negative	Stage IIIA	No_Conversion	enrollment	LIVING	9	NA	0	9	Luminal B	-3	-1	2	2	Basal	3	4	3	3
96	TCGA-AN-A0FK	FEMALE	88	Positive	Positive	Negative	T4	T_Other	N0	Negative	M0	Negative	Stage IIIB	No_Conversion	enrollment	LIVING	212	NA	0	212	Luminal B	-3	-12	4	2	LumA	2	4	3	3
97	TCGA-AR-A0TT	FEMALE	53	Positive	Negative	Negative	T2	T_Other	N2	Positive	M0	Negative	Stage III	No_Conversion	enrollment	LIVING	1679	NA	0	1679	Luminal B	-5	-2	4	1	LumA/B	3	4	1	1
98	TCGA-AR-A0TV	FEMALE	66	Positive	Positive	Negative	T2	T_Other	N0	Negative	M0	Negative	Stage II	No_Conversion	enrollment	LIVING	904	NA	0	904	Luminal B	-5	-10	2	4	LumA/B	1	4	1	1
99	TCGA-AR-A1AV	MALE	68	Positive	Positive	Negative	T2	T_Other	N1	Positive	M0	Negative	Stage II	Stage IIB	enrollment	LIVING	1295	NA	0	1295	Luminal B	-5	-2	7	3	LumA/B	3	4	4	5
100	TCGA-BH-A0BZ	FEMALE	59	Positive	Positive	Negative	T3	T_Other	N1	Positive	M0	Negative	Stage IIIA	Stage IIIA	enrollment	LIVING	1492	NA	0	1492	Luminal B	-5	-2	6	4	X	4	4	1	1